International
Dragon Pharma Kisspeptin 10 mg (Metastin) Research Peptide Vial
Injection · 10 mg · vial
Dragon Pharma Kisspeptin 10 mg is kisspeptin-10 (metastin), a research peptide supplied as a lyophilised 10 mg vial. It acts as a kisspeptin receptor agonist at the top of the reproductive axis, triggering GnRH release and through it LH and FSH.
Each vial is GMP-manufactured and HPLC-verified, with a Certificate of Analysis on file. Reconstitute with bacteriostatic water. Kisspeptin 10 mg for sale with U.S. domestic and international shipping.
Product overview
Dragon Pharma Kisspeptin 10 mg - Metastin Research Peptide
Dragon Pharma Kisspeptin 10 mg delivers kisspeptin-10, the peptide also called metastin, as a lyophilised 10 mg vial. It is a research material for laboratory work on the reproductive axis rather than an approved medicine, and the fact sheet records no human label for this form. Kisspeptin 10 mg for sale from a GMP manufacturer, with third-party testing and a Certificate of Analysis on file per batch.
- Kisspeptin-10 (metastin) - 10 mg per lyophilised vial
- Ligand of GPR54 (Kiss1R) - stimulates GnRH release
- Reference half-life about 4 minutes after an intravenous bolus
- GMP-manufactured, HPLC-verified, COA on file per batch
How Kisspeptin-10 Works
Kisspeptin-10 binds the kisspeptin receptor GPR54, also written Kiss1R, on hypothalamic neurons and drives GnRH secretion. Because GnRH sits above LH and FSH, a bolus moves the whole downstream chain: in healthy men an intravenous bolus raised serum LH and FSH already at 0.3 and 1.0 nmol per kg, while in women the response depended on cycle phase, with no rise in the follicular phase and a clear rise in the preovulatory phase at 10 nmol per kg. That very short action window is why laboratory work uses frequent boluses or infusion instead of one injection.
Research Amounts and Handling
No dose is approved for human use, so every figure below is research practice. Vendor and academic material describes 6 to 10 mcg per kg subcutaneously, flat amounts of 100 to 500 mcg per injection, and infusion protocols of 4 mcg per kg per hour, all from studies of the intravenous peptide. Reconstitute the 10 mg vial with bacteriostatic water: at 2 ml the concentration is 5 mg per ml and a 0.5 mg amount measures 0.1 ml; at 1 ml it is 10 mg per ml and the same amount measures 0.05 ml. Store the powder at 2-8 C away from light. Aldosterone stimulation and injection site reactions are the reported effects.
Quality & Authenticity
Every batch is produced under GMP conditions and checked by independent HPLC, with the Certificate of Analysis held for the batch. The fact sheet lists kisspeptin and its agonists under WADA class S2, prohibited at all times. Kisspeptin is not the same product as PT-141 or the gonadotropin HCG, and it is not a GH secretagogue such as Sermorelin.
For laboratory research only. Consult a healthcare professional before use.
Specifications
| Trade Name | Kisspeptin 10 mg |
| Generic Name | Kisspeptin-10 (metastin) |
| Manufacturer | Dragon Pharma |
| Dosage | 10 mg per lyophilised vial |
| Package | 1 vial of powder for reconstitution |
| Drug Class | Research peptide, kisspeptin receptor (GPR54) agonist |
| Administration | Reconstitute with bacteriostatic water, subcutaneous injection |
| Reference Half-Life | About 4 minutes after an intravenous bolus in humans |
| Shipping | International and U.S. domestic options |
Stacks
Consult a healthcare professional before any cycle. Doses are common community protocols.
FAQ
Before you ask
Questions, answered
It is kisspeptin-10, also called metastin, supplied as a lyophilised 10 mg vial. The peptide is an RF-amide ligand of the receptor GPR54, also written Kiss1R, and it stimulates the release of GnRH at the top of the reproductive axis. It is sold as a research-grade material: the fact sheet records no approved human product label for this vial form, so it is not a medicine.
Kisspeptin-10 binds the kisspeptin receptor on hypothalamic neurons and increases GnRH secretion, which in turn drives LH and FSH release. In healthy men an intravenous bolus raised serum LH and FSH at 0.3 and 1.0 nmol per kg. In women the effect depended on cycle phase, with no LH or FSH response in the follicular phase and a rise in the preovulatory phase at 10 nmol per kg.
The fact sheet quotes about four minutes after an intravenous bolus in humans, roughly seven times shorter than kisspeptin-54. That short window is why laboratory work uses frequent boluses or infusion rather than a single injection. The value comes from studies of the intravenous peptide, not from a published profile of a subcutaneous research vial.
No human dose is approved, so every figure is research practice. Vendor and academic material describes 6 to 10 mcg per kg subcutaneously, flat amounts of 100 to 500 mcg per injection, and infusion protocols of 4 mcg per kg per hour, all derived from studies of the intravenous form. A typical reconstitution of this vial is 10 mg of powder in 2 ml of bacteriostatic water, giving 5 mg per ml.
The fact sheet records flushing after a bolus, stimulation of aldosterone, and injection site reactions such as pain or redness. Hepatic load is rated low only because no human hepatotoxicity data were found, so that rating reflects missing data rather than a clean safety record. Systematic human data for a research vial of this kind do not exist.
Keep the lyophilised vial at 2-8 C, protected from light, and avoid repeated freezing and thawing. Add bacteriostatic water down the wall of the vial without shaking. Once reconstituted, keep the solution refrigerated and follow vendor guidance on short use windows, because an exact shelf life for this vial is not confirmed in the sources used here.
Be the first to share your experience with Dragon Pharma Kisspeptin 10 mg (Metastin) Research Peptide Vial
Log in to write a reviewComplete the cycle
Stack it with
International
International
Available Domestic
International
Available Domestic